Source: International Congress 2019 – Airway infection in COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Perea (Barcelona, Spain), A. Rodrigo-Troyano (Barcelona, Spain), E. Cantó (Barcelona, Spain), M. Domínguez-Álvarez (Barcelona, Spain), J. Giner (Barcelona, Spain), F. Sánchez-Reus (Barcelona, Spain), A. Torrego (Barcelona, Spain), J. Villar-García (Barcelona, Spain), S. Quero (Barcelona, Spain), M. Garcia (Barcelona, Spain), E. Monsó (Barcelona, Spain), R. Faner (Barcelona, Spain), A. Agustí (Barcelona, Spain), S. Vidal (Barcelona, Spain), O. Sibila (Barcelona, Spain). Airway FABP4 is decreased in COPD patients with airway bacterial infection. 2894

Member's Comments

No comment yet.

Related content which might interest you: Variation in the TLR4 gene and airway inflammation among patients with COPD Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Airway inflammation and upper airway infection in asthmatic children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 Bacterial airway colonization is not associated with increased procalcitonin in stable COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Airway inflammation markers in COPD Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Protein profile of COPD patients with Pseudomonas in their airway secretions Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients Source: Eur Respir J 2008; 32: 740-747 Year: 2008 Bacterial infection in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 Airway inflammation and airway pathophysiology in older asthmatics Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 The impact of bacterial colonisation on airway inflammation in stable COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Airway resistance in COPD Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 ADAM33 SNPs are associated with airway hyperresponsiveness and airway inflammation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005 Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006